盐酸雷洛昔芬结构式
|
常用名 | 盐酸雷洛昔芬 | 英文名 | Raloxifene HCl |
---|---|---|---|---|
CAS号 | 82640-04-8 | 分子量 | 510.044 | |
密度 | 1.285g/cm3 | 沸点 | 728.2ºC at 760 mmHg | |
分子式 | C28H28ClNO4S | 熔点 | 143-147ºC | |
MSDS | 中文版 美版 | 闪点 | 394.2ºC |
盐酸雷洛昔芬用途Raloxifene hydrochloride (LY156758 hydrochloride) 是第二代雌激素受体拮抗剂。 |
中文名 | 盐酸雷洛昔芬 |
---|---|
英文名 | raloxifene hydrochloride |
中文别名 | [6-羟基-2-(4-羟苯基)苯并[b]噻酚-3-基]-[4-[2-(1-哌啶基)乙氧基]-苯基]-甲酮盐酸盐 | 雷洛西芬中间体 |
英文别名 | 更多 |
描述 | Raloxifene hydrochloride (LY156758 hydrochloride) 是第二代雌激素受体拮抗剂。 |
---|---|
相关类别 | |
参考文献 |
密度 | 1.285g/cm3 |
---|---|
沸点 | 728.2ºC at 760 mmHg |
熔点 | 143-147ºC |
分子式 | C28H28ClNO4S |
分子量 | 510.044 |
闪点 | 394.2ºC |
精确质量 | 509.142761 |
PSA | 98.24000 |
LogP | 6.81510 |
外观性状 | 淡黄色固体 |
折射率 | 1.654 |
储存条件 | -20°C Freezer |
水溶解性 | DMSO: 28 mg/mL, soluble |
盐酸雷洛昔芬上游产品 10 | |
---|---|
盐酸雷洛昔芬下游产品 1 | |
Oxidative metabolic pathway of lenvatinib mediated by aldehyde oxidase.
Drug Metab. Dispos. 42(8) , 1326-33, (2014) Lenvatinib is a multityrosine kinase inhibitor that inhibits vascular endothelial growth factor receptors, and is being developed as an anticancer drug. P450s are involved in one of the elimination pa... |
|
Selective estrogen-receptor modulators suppress microglial activation and neuronal cell death via an estrogen receptor-dependent pathway.
J. Steroid Biochem. Mol. Biol. 145 , 85-93, (2015) Growing evidence shows that steroid hormones, especially 17β-estradiol (E2), protect neuronal cells by attenuating excess activation of microglia. However, the use of E2 in the clinic is controversial... |
|
Bioluminescent cell-based NAD(P)/NAD(P)H assays for rapid dinucleotide measurement and inhibitor screening.
Assay Drug Dev. Technol. 12(9-10) , 514-26, (2014) Abstract The central role of nicotinamide adenine dinucleotides in cellular energy metabolism and signaling makes them important nodes that link the metabolic state of cells with energy homeostasis an... |
[6-hydroxy-2-(4-hydroxyphenyl)-1-benzothiophen-3-yl][4-(2-piperidin-1-ylethoxy)phenyl]methanone hydrochloride |
[6-Hydroxy-2-(4-hydroxyphenyl)-1-benzothiophen-3-yl]{4-[2-(piperidin-1-yl)ethoxy]phenyl}methanone hydrochloride (1:1) |
Raloxifene HCl |
[6-Hydroxy-2-(4-hydroxyphenyl)-1-benzothiophen-3-yl][4-(2-piperidin-1-ylethoxy)phenyl]methanonhydrochlorid |
1-[2-(4-{[6-Hydroxy-2-(4-hydroxyphenyl)-1-benzothiophen-3-yl]carbonyl}phenoxy)ethyl]piperidinium chloride |
[6-Hydroxy-2-(4-hydroxyphenyl)-1-benzothiophen-3-yl]{4-[2-(1-piperidinyl)ethoxy]phenyl}methanone hydrochloride (1:1) |
Methanone, [6-hydroxy-2-(4-hydroxyphenyl)benzo[b]thien-3-yl][4-[2-(1-piperidinyl)ethoxy]phenyl]-, hydrochloride (1:1) |
methanone, [6-hydroxy-2-(4-hydroxyphenyl)benzo[b]thien-3-yl][4-[2-(1-piperidinyl)ethoxy]phenyl]-, hydrochloride |
6-Hydroxy-2-(p-hydroxyphenyl)benzo(b)thien-3-yl-p-(2-piperidinoethoxy)phenyl ketone hydrochloride |
MFCD01938233 |
Raloxifene hydrochloride |
Raloxifene (hydrochloride) |